A study presented at ENDO 2025 by Dr. Shellsea Portillo Canales (SSM Health, St. Louis University Hospital) found that widely used GLP‑1 receptor agonists—semaglutide, dulaglutide, and tirzepatide—were associated with significant improvements in testosterone among obese men, many of whom also had type 2 diabetes. After 18 months, the share
Dr. N. Sapna Lulla, Lead Consultant, Obstetrics & Gyneacology, Aster CMI Hospital, BangaloreNeurological disorders include various conditions affecting the nervous system, with implications extending beyond motor and cognitive functions. Surprisingly, these disorders can also impact fertility, disrupting the complex network of signals between the brain
